Priprema 11.2012.fh11 - Državni zavod za intelektualno vlasništvo

3574 HR - Patenti - Hrvatski glasnik intelektualnog vlasništva 19, 2012, 11, 3513 – 3661Kazalo klasifikacijskih oznaka zahtjevaza proširenje europskih prijavapatenata prema Međunarodnojklasifikaciji patenataMKP Broj objave europske Naziv izumaprijave patenta(51) (97) (54)A01K 61/00 (2006.01) EP 2520163 A float and a floatable structureA23B 9/28 (2006.01) EP 2426195 CompositionA23J 7/00 (2006.01) EP 2431020 Processes for the separation and purification of phosphatidylserineA24D 3/08 (2006.01) EP 2510815 Selective filtration of cigarette smoke using chitosan derivativesA61F 2/00 (2006.01) EP 2431036 Macrocyclic lactone compounds and methods for their useA61F 2/90 (2006.01) EP 2431036 Macrocyclic lactone compounds and methods for their useA61F 2/92 (2006.01) EP 2431036 Macrocyclic lactone compounds and methods for their useA61F 5/14 (2006.01) EP 2382952 Adjustable orthoticA61J 7/00 (2006.01) EP 2258349 Swellable dosage form comprising gellan gumA61K 31/167 (2006.01) EP 2258349 Swellable dosage form comprising gellan gumA61K 31/192 (2006.01) EP 2258349 Swellable dosage form comprising gellan gumExtended release pellet formulation containing Pramipexole or a pharmaceutically acceptableA61K 31/428 (2006.01) EP 2431026salt thereof, method for manufacturing the same and use thereofExtended release pellet formulation containing Pramipexole or a pharmaceutically acceptablesalt thereof, method for manufacturing the same and use thereofA61K 31/428 (2006.01) EP 2431027A61K 31/436 (2006.01) EP 2431036 Macrocyclic lactone compounds and methods for their useA61K 31/4415 (2006.01) EP 2258349 Swellable dosage form comprising gellan gumA61K 31/444 (2006.01) EP 2388258 Novel vanilloid receptor ligands and their use for producing medicamentsA61K 31/453 (2006.01) EP 2431036 Macrocyclic lactone compounds and methods for their useA61K 31/4985 (2006.01) EP 2397142 Use of dpp iv inhibitorsA61K 31/522 (2006.01) EP 2397142 Use of dpp iv inhibitorsA61K 31/787 (2006.01) EP 2431036 Macrocyclic lactone compounds and methods for their useA61K 33/26 (2006.01) EP 2258349 Swellable dosage form comprising gellan gumA61K 38/17 (2006.01) EP 2388013 C-reactive protein and its use to treat systemic Lupus erythematosus and related conditionsA61K 38/36 (2006.01) EP 2431389 Compositions and methods for modulating hemostasisA61K 38/36 (2006.01) EP 2431390 Compositions and methods for modulating hemostasisA61K 38/48 (2006.01) EP 2428218 Modified proteases that inhibit complement activationA61K 38/49 (2006.01) EP 2428218 Modified proteases that inhibit complement activationA61K 39/02 (2006.01) EP 2425851 Multivalent Pneumococcal Polysaccharide-Protein Conjugate CompositionA61K 39/02 (2006.01) EP 2425852 Multivalent Pneumococcal Polysaccharide-Protein Conjugate CompositionA61K 39/02 (2006.01) EP 2425853 Multivalent Pneumococcal Polysaccharide-Protein Conjugate CompositionA61K 39/02 (2006.01) EP 2425854 Multivalent pneumococcal polysaccharide-protein conjugate compositionA61K 39/02 (2006.01) EP 2425855 Multivalent pneumococcal polysaccharide-protein conjugate compositionA61K 39/02 (2006.01) EP 2425856 Multivalent pneumococcal polysaccharide-protein conjugate compositionA61K 39/09 (2006.01) EP 2425851 Multivalent Pneumococcal Polysaccharide-Protein Conjugate CompositionA61K 39/09 (2006.01) EP 2425852 Multivalent Pneumococcal Polysaccharide-Protein Conjugate CompositionA61K 39/09 (2006.01) EP 2425853 Multivalent Pneumococcal Polysaccharide-Protein Conjugate CompositionA61K 39/09 (2006.01) EP 2425854 Multivalent pneumococcal polysaccharide-protein conjugate compositionA61K 39/09 (2006.01) EP 2425855 Multivalent pneumococcal polysaccharide-protein conjugate compositionA61K 39/09 (2006.01) EP 2425856 Multivalent pneumococcal polysaccharide-protein conjugate compositionA61K 39/295 (2006.01) EP 2425851 Multivalent Pneumococcal Polysaccharide-Protein Conjugate CompositionA61K 39/295 (2006.01) EP 2425852 Multivalent Pneumococcal Polysaccharide-Protein Conjugate CompositionA61K 39/295 (2006.01) EP 2425853 Multivalent Pneumococcal Polysaccharide-Protein Conjugate CompositionA61K 39/295 (2006.01) EP 2425854 Multivalent pneumococcal polysaccharide-protein conjugate compositionA61K 39/295 (2006.01) EP 2425855 Multivalent pneumococcal polysaccharide-protein conjugate compositionA61K 39/295 (2006.01) EP 2425856 Multivalent pneumococcal polysaccharide-protein conjugate compositionA61K 39/395 (2006.01) EP 2402373 Anti-EphB4 Antibodies and Methods Using SameA61K 39/395 (2006.01) EP 2425851 Multivalent Pneumococcal Polysaccharide-Protein Conjugate CompositionA61K 39/395 (2006.01) EP 2425852 Multivalent Pneumococcal Polysaccharide-Protein Conjugate CompositionA61K 39/395 (2006.01) EP 2425853 Multivalent Pneumococcal Polysaccharide-Protein Conjugate CompositionA61K 39/395 (2006.01) EP 2425854 Multivalent pneumococcal polysaccharide-protein conjugate compositionA61K 39/395 (2006.01) EP 2425855 Multivalent pneumococcal polysaccharide-protein conjugate compositionA61K 39/395 (2006.01) EP 2425856 Multivalent pneumococcal polysaccharide-protein conjugate compositionA61K 39/395 (2006.01) EP 2518083Combination of angiopoietin-2 antagonist and of VEGF-A, KDR and/or FLTL antagonist fortreating cancerCombination of angiopoietin-2 antagonist and of VEGF-A, KDR and/or FLTL antagonist fortreating cancerA61K 45/06 (2006.01) EP 2518083A61K 47/00 (2006.01) EP 2431036 Macrocyclic lactone compounds and methods for their useConjugates having a degradable linkage and polymeric reagents useful in preparing suchconjugatesA61K 47/48 (2006.01) EP 2279758A61K 47/48 (2006.01) EP 2431020 Processes for the separation and purification of phosphatidylserineA61K 8/14 (2006.01) EP 2431020 Processes for the separation and purification of phosphatidylserineA61K 8/55 (2006.01) EP 2431020 Processes for the separation and purification of phosphatidylserineA61K 9/00 (2006.01) EP 2431036 Macrocyclic lactone compounds and methods for their useA61K 9/16 (2006.01) EP 2258349 Swellable dosage form comprising gellan gumISSN 1847-3024